Arcturus Therapeutics Holdings Inc. Stock News

The race for a coronavirus (COVID-19) vaccine is on in the ugliest of ways. Since December, scientists around the world have been racing to create the first vaccine against COVID-19, with vaccine tria

50 hospitals will try to resolve the best way to use these drugs.

Cash and Margin: Be cautious and thoughtful, not fearful and frozen. Housing and Mortgages: Expect transactions to fall off a cliff. The time to refinance is no

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.

European stock markets and U.S. stocks futures are down sharply on Wednesday, as investors weigh up whether plans by governments to prevent a global recession from the coronavirus would be enough.

Toward the end of trading Monday, the Dow traded down 10.19% to 20,822.15 while the NASDAQ fell 9.87% to 7,097.62. The S&P also fell, dropping 9.73% to 7,108.79. South Korea...

JP Morgan cut Workday Inc (NASDAQ: WDAY) price target from $190 to $175. Workday shares closed at $142.03 on Wednesday. H.C. Wainwright raised the price target for Arcturus...

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) * Bicycle Therapeutics PLC (NASDAQ: BCYC) (reacte

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 11) Bicycle Therapeutics...

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A

Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) * Arcus Biosciences Inc (NYSE: RCUS) * Arcturu

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 4) * 89bio Inc (NASDAQ: ETNB) * Arcus Biosciences In

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Arcturus Therapeutics ( ARCT – Research Report ), with a price target of $18.00 . The company’s shares closed la

Cellect Biotechnology (NASDAQ:APOP) +38% on Canndoc deal.Dynatronics (NASDAQ:DYNT) +28%.AIM ImmunoTech (NYSEMKT:AIM) +24% on recent announcements on Covid-19 front.Arcturus Therapeutics Holdings (NA

Recent announcements on the COVID-19 front:Luminex (NASDAQ:LMNX): Working on two SARS-Cov-2 tests: NxTAG CoV Expanded Panel: should be available to ship to customers in a few weeks. Testing in China t